IVA337 + IVA337 + Placebo
Phase 2Completed 1 views this week 0 watching💤 Quiet
Interest: 29/100
29
Development Stage
✓
Pre-clinical✓
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Non-Alcoholic Steatohepatitis (NASH)
Conditions
Non-Alcoholic Steatohepatitis (NASH)
Trial Timeline
Feb 7, 2017 → Mar 16, 2020
NCT ID
NCT03008070About IVA337 + IVA337 + Placebo
IVA337 + IVA337 + Placebo is a phase 2 stage product being developed by Inventiva for Non-Alcoholic Steatohepatitis (NASH). The current trial status is completed. This product is registered under clinical trial identifier NCT03008070. Target conditions include Non-Alcoholic Steatohepatitis (NASH).
What happened to similar drugs?
0 of 4 similar drugs in Non-Alcoholic Steatohepatitis (NASH) were approved
Approved (0) Terminated (0) Active (4)
Hype Score Breakdown
Clinical
12
Activity
8
Company
9
Novelty
0
Community
0
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT03008070 | Phase 2 | Completed |
Competing Products
20 competing products in Non-Alcoholic Steatohepatitis (NASH)